vs

Side-by-side financial comparison of iRhythm Holdings, Inc. (IRTC) and NATIONAL PRESTO INDUSTRIES INC (NPK). Click either name above to swap in a different company.

iRhythm Holdings, Inc. is the larger business by last-quarter revenue ($208.9M vs $164.0M, roughly 1.3× NATIONAL PRESTO INDUSTRIES INC). On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs 21.7%). iRhythm Holdings, Inc. produced more free cash flow last quarter ($14.5M vs $12.4M). Over the past eight quarters, NATIONAL PRESTO INDUSTRIES INC's revenue compounded faster (46.3% CAGR vs 25.8%).

iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.

National Presto Industries is a company founded in 1905 in Eau Claire, Wisconsin. Originally called "Northwestern Steel and Iron Works" the company changed its name to the "National Pressure Cooker Company" in 1929 and then National Presto Industries, Inc. 1953. The company originally produced pressure canners for commercial, and later home, use. Beginning in 1939, the company introduced small home-use cooking appliances. The company was admitted to the New York Stock Exchange on March 3, 1969.

IRTC vs NPK — Head-to-Head

Bigger by revenue
IRTC
IRTC
1.3× larger
IRTC
$208.9M
$164.0M
NPK
Growing faster (revenue YoY)
IRTC
IRTC
+5.4% gap
IRTC
27.1%
21.7%
NPK
More free cash flow
IRTC
IRTC
$2.1M more FCF
IRTC
$14.5M
$12.4M
NPK
Faster 2-yr revenue CAGR
NPK
NPK
Annualised
NPK
46.3%
25.8%
IRTC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IRTC
IRTC
NPK
NPK
Revenue
$208.9M
$164.0M
Net Profit
$5.6M
Gross Margin
70.9%
16.9%
Operating Margin
1.1%
11.4%
Net Margin
2.7%
Revenue YoY
27.1%
21.7%
Net Profit YoY
518.5%
EPS (diluted)
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRTC
IRTC
NPK
NPK
Q4 25
$208.9M
$164.0M
Q3 25
$192.9M
$115.5M
Q2 25
$186.7M
$120.4M
Q1 25
$158.7M
$103.6M
Q4 24
$164.3M
$134.7M
Q3 24
$147.5M
$91.8M
Q2 24
$148.0M
$85.1M
Q1 24
$131.9M
$76.7M
Net Profit
IRTC
IRTC
NPK
NPK
Q4 25
$5.6M
Q3 25
$-5.2M
$5.3M
Q2 25
$-14.2M
$5.2M
Q1 25
$-30.7M
$7.6M
Q4 24
$-1.3M
Q3 24
$-46.2M
$8.1M
Q2 24
$-20.1M
$6.1M
Q1 24
$-45.7M
$6.6M
Gross Margin
IRTC
IRTC
NPK
NPK
Q4 25
70.9%
16.9%
Q3 25
71.1%
13.9%
Q2 25
71.2%
15.4%
Q1 25
68.8%
17.5%
Q4 24
70.0%
24.3%
Q3 24
68.8%
18.8%
Q2 24
69.9%
17.3%
Q1 24
66.3%
18.1%
Operating Margin
IRTC
IRTC
NPK
NPK
Q4 25
1.1%
11.4%
Q3 25
-4.4%
5.6%
Q2 25
-10.0%
5.1%
Q1 25
-20.5%
8.8%
Q4 24
-2.5%
17.3%
Q3 24
-34.1%
10.0%
Q2 24
-15.5%
7.5%
Q1 24
-28.9%
8.2%
Net Margin
IRTC
IRTC
NPK
NPK
Q4 25
2.7%
Q3 25
-2.7%
4.6%
Q2 25
-7.6%
4.3%
Q1 25
-19.3%
7.3%
Q4 24
-0.8%
Q3 24
-31.3%
8.8%
Q2 24
-13.6%
7.1%
Q1 24
-34.6%
8.6%
EPS (diluted)
IRTC
IRTC
NPK
NPK
Q4 25
$0.18
Q3 25
$-0.16
Q2 25
$-0.44
Q1 25
$-0.97
Q4 24
$-0.03
Q3 24
$-1.48
Q2 24
$-0.65
Q1 24
$-1.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRTC
IRTC
NPK
NPK
Cash + ST InvestmentsLiquidity on hand
$583.8M
$3.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$152.7M
$395.1M
Total Assets
$1.0B
$500.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRTC
IRTC
NPK
NPK
Q4 25
$583.8M
$3.8M
Q3 25
$565.2M
$4.6M
Q2 25
$545.5M
$4.8M
Q1 25
$520.6M
$5.5M
Q4 24
$535.6M
$22.7M
Q3 24
$522.0M
$33.2M
Q2 24
$561.5M
$53.4M
Q1 24
$569.1M
$87.9M
Stockholders' Equity
IRTC
IRTC
NPK
NPK
Q4 25
$152.7M
$395.1M
Q3 25
$121.9M
$379.8M
Q2 25
$103.7M
$374.1M
Q1 25
$86.7M
$368.6M
Q4 24
$90.9M
$367.6M
Q3 24
$71.8M
$346.6M
Q2 24
$99.2M
$338.1M
Q1 24
$90.3M
$331.6M
Total Assets
IRTC
IRTC
NPK
NPK
Q4 25
$1.0B
$500.7M
Q3 25
$995.2M
$503.8M
Q2 25
$964.0M
$471.9M
Q1 25
$926.1M
$455.3M
Q4 24
$931.4M
$453.4M
Q3 24
$909.7M
$428.9M
Q2 24
$919.2M
$418.1M
Q1 24
$909.8M
$417.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRTC
IRTC
NPK
NPK
Operating Cash FlowLast quarter
$26.2M
$13.9M
Free Cash FlowOCF − Capex
$14.5M
$12.4M
FCF MarginFCF / Revenue
6.9%
7.6%
Capex IntensityCapex / Revenue
5.6%
0.9%
Cash ConversionOCF / Net Profit
4.70×
TTM Free Cash FlowTrailing 4 quarters
$34.5M
$-36.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRTC
IRTC
NPK
NPK
Q4 25
$26.2M
$13.9M
Q3 25
$34.9M
$-24.6M
Q2 25
$27.7M
$-10.9M
Q1 25
$-7.9M
$12.5M
Q4 24
$19.2M
$-7.6M
Q3 24
$24.3M
$-17.5M
Q2 24
$11.8M
$-33.9M
Q1 24
$-52.0M
$5.6M
Free Cash Flow
IRTC
IRTC
NPK
NPK
Q4 25
$14.5M
$12.4M
Q3 25
$20.1M
$-24.7M
Q2 25
$17.3M
$-13.4M
Q1 25
$-17.3M
$-10.5M
Q4 24
$12.4M
$-11.3M
Q3 24
$15.5M
$-20.3M
Q2 24
$3.4M
$-34.5M
Q1 24
$-61.8M
$5.2M
FCF Margin
IRTC
IRTC
NPK
NPK
Q4 25
6.9%
7.6%
Q3 25
10.4%
-21.4%
Q2 25
9.3%
-11.1%
Q1 25
-10.9%
-10.2%
Q4 24
7.5%
-8.4%
Q3 24
10.5%
-22.1%
Q2 24
2.3%
-40.6%
Q1 24
-46.8%
6.7%
Capex Intensity
IRTC
IRTC
NPK
NPK
Q4 25
5.6%
0.9%
Q3 25
7.7%
0.1%
Q2 25
5.6%
2.0%
Q1 25
5.9%
22.2%
Q4 24
4.2%
2.7%
Q3 24
6.0%
3.1%
Q2 24
5.7%
0.8%
Q1 24
7.4%
0.5%
Cash Conversion
IRTC
IRTC
NPK
NPK
Q4 25
4.70×
Q3 25
-4.63×
Q2 25
-2.12×
Q1 25
1.64×
Q4 24
Q3 24
-2.16×
Q2 24
-5.58×
Q1 24
0.85×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IRTC
IRTC

Commercial Payors$111.7M53%
Centers For Medicare And Medicaid$49.2M24%
Healthcare Institutions$34.3M16%
Non Contracted Third Party Payors$13.7M7%

NPK
NPK

Segment breakdown not available.

Related Comparisons